<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49518">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02461576</url>
  </required_header>
  <id_info>
    <org_study_id>177B</org_study_id>
    <nct_id>NCT02461576</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Xpert® HIV-1 VL</brief_title>
  <official_title>Clinical Evaluation of the Xpert® HIV-1 VL: A Method Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cepheid</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cepheid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the clinical performance of the Xpert® HIV-1 VL to another FDA approved HIV-1 RNA
      quantitative assay using frozen and fresh specimens from known HIV-1 positive individuals.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of HIV-1 RNA in copies/mL in known HIV-1 positive subjects</measure>
    <time_frame>1 day (A single time point)</time_frame>
    <description>This study is a comparative analysis of HIV-1 RNA quantitation between Xpert HIV-1 VL to another FDA approved test. A single time point (cross-sectional) from each of at least 300 subjects with HIV-1 RNA quantitation within the dynamic range of both assays will be used in regression models to assess performance of the Xpert HIV-1 VL in comparison to the other FDA approved test.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Human Immunodeficiency Virus</condition>
  <arm_group>
    <arm_group_label>HIV-1 infected</arm_group_label>
    <description>this is a study comparing Xpert HIV-1 VL assay quantitation to an already FDA approved HIV-1 quantitative HIV-1 RNA assay in known HIV-1 infected individuals</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xpert HIV-1 VL Assay</intervention_name>
    <description>in vitro diagnostic test to quantify HIV-1 RNA</description>
    <arm_group_label>HIV-1 infected</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Leftover plasma specimens will be retained in a biobank.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Males and females &gt;18 yours who are known HIV-1 infected and may be on treatment or
        untreated with ARV therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-1 seropositive adults using an FDA approved method

          -  At least 18 years of age or older

          -  Informed consent, if applicable

        Exclusion Criteria:

          -  Subject is less than 18 years of age

          -  Previously enrolled in this study

          -  Samples not collected according to the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2015</verification_date>
  <lastchanged_date>June 2, 2015</lastchanged_date>
  <firstreceived_date>May 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV-1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
